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Abstract
Background
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive and life-limiting condition.
From a healthcare perspective it is vital to establish effective methods of improving the qual-
ity of remaining life in these patients. This requires a detailed understanding of the multiple
impacts of an IPF diagnosis on the individual.
Methods
We sought to understand how patients coped with their initial diagnosis, how they live with
the disease day-to-day, and their experiences and opinions of the professional support
they receive. A patient-centred approach was used to explore the social, psychological and
physical impacts of IPF. Semi-structured interviews were conducted by an experienced aca-
demic. Interview questions were written by the researchers but guided by informal conversa-
tions with patients and clinicians. An inductive thematic approach was used to analyse the
data, allowing us to identify common themes in the patients’ experiences.
Results
Of fifty invited participants, ten took part in the study (aged 53–81 years; 9 male). Inductive
analysis of interviews identified seven second-order themes and eleven first-order themes,
represented by two General Dimensions: ‘Patient experience with the condition’ and
‘Patient-led recommendations for practice’. The key message on ‘coping’ in these patients
was that acceptance of their condition led to a sense of optimism. Participants reported
using appraisal-focused coping strategies to change their perspectives (thinking positively)
and emotion-focused strategies to overcome depression (the main opportunity for emotional
expression being an IPF support group). The support group also facilitated problem-focused
coping: individuals exchanged knowledge and experience and gave one another tips on
how to live with their condition.
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Conclusions
Health professionals should provide patients with information that focuses on living with IPF,
encouraging them to make lifestyle changes and adaptations to improve quality of life. Fam-
ily members should receive education about IPF so that they can support such changes.
Patients should be encouraged to join a support group and to participate in physical activity
(again preferably group-based). This study offers novel findings that will help inform much-
needed changes in the practice of supporting IPF patients to cope with their diagnosis and
disease progression.
Introduction
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive and life-limiting disease of the
lungs. It’s cause is unknown but it is recognised as a distinct clinical form of the idiopathic inter-
stitial pneumonias [1]. Progressive fibrosis of the alveolar walls causes impairment of gas
exchange, decline in lung function and ultimately, death from respiratory failure. Consequently,
patients with IPF present with symptoms of increasing breathlessness and fatigue whilst many
also develop a dry cough, which can prove difficult to treat. In the UK, IPF has an annual inci-
dence of 4.6 per 100,000 and this is increasing by 5% per annum, a trend mirrored by hospital
admission rates [2]. Whilst new therapies that slow the decline in lung function have recently
been recommended for IPF (Nintedanib and Pirfenidone) [1] there is still no cure. The median
survival for patients diagnosed with IPF is 2.5 to 3.5 years although the range is wide [3], some
following a slowly declining trajectory over many years whilst others may have a rapidly pro-
gressive course. Thus, individual patients are confronted with both the physical limitations
imposed by the disease and the psychological impact of an ultimately fatal condition with uncer-
tain rate of progression. Therefore, an important aspect of caring for people with IPF is to help
preserve their Quality of Life (QoL), taking into account the impact thereon of physical, psycho-
logical and social wellbeing [4,5]. A recent review [6] highlighted studies that have attempted to
measure or improve QoL in IPF (using patient-reported outcome measures and interventions)
and those that have identified unmet patient needs (such as emotional support and information
resources). A few studies have assessed the individual psychological impact of an IPF diagnosis
and also patients’ experiences of living with the disease [7–11].
The aim of this study was to explore the idiographic experiences of patients with IPF within
our local health board in South West Wales, and thus to improve our understanding of the
psychosocial impact of the disease in this region. We used a qualitative interview approach
that enabled patients to ‘tell their own stories in their own words’, so that they could focus on
the issues and experiences that had personal meaning for them in four specific areas: how they
coped after receiving the diagnosis; how they live with the disease day-to-day; their experiences
and opinions of the professional support they received; and their views on the pulmonary
rehabilitation programme they were offered. In so doing, we hoped to gain insight into how to
best support the psychological needs of individuals diagnosed with IPF.
Materials and methods
Participants
The study was performed in accordance with the Declaration of Helsinki. Ethical approval to
conduct the study was obtained from the School of Sport and Exercise Sciences Ethics
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Committee at Swansea University. Members of the research team attended a monthly support
group for IPF patients held in a community setting in Swansea (South West Wales, UK), fol-
lowing which they approached patients to invite them to participate in the study. (The support
group meetings aimed to provide an opportunity for IPF patients to meet in a social setting
and, if they wished, to discuss their experiences of the disease and thus to support one another
—for example regarding anxieties and coping with the challenges of daily living.) Patients who
agreed to participate were then contacted individually by letter to arrange the interviews,
which were conducted at Swansea University. All recruited individuals provided their written
informed consent to participate in the study. Our purposive sampling criteria required that
participants had been diagnosed with IPF, were aged 18 years or older and were able to write
and converse in English (to facilitate data collection). Given the individuality of the disease, we
contacted a large pool of patients (50 individuals) to recruit a variation sample that would
allow us to capture a wide range of perspectives from participants.
Method
Participants attended semi-structured interviews conducted by two of the authors (SS, JH) fol-
lowing monthly support group meetings held in Swansea, South West Wales. Participants
attended semi-structured interviews conducted by two members of the researcher team. Inter-
views lasted 45–60 minutes and were audio recorded and transcribed verbatim. An inductive
thematic approach [12] was used to analyse the transcribed data: raw data themes were
recorded during the interviews and these were tracked and continually revised throughout the
transcription process. Details of the interview procedure (including example interview ques-
tions) and the data analysis methods used are provided in S1 File.
Results
A total of 50 IPF patients registered in the support group were contacted by post and 10 volun-
teered to take part in the study. No replies were obtained from the other 40 individuals, and no
explanations were sought from those who did not respond (in line with our ethical approval).
After analysing the transcripts from these ten participants the research team considered that
data saturation had been reached and so no additional patients were invited to participate. The
study participants ranged in age from 53 to 81 years (mean = 70.5 ± 10.4 years), one of whom
was female. Participants reported durations of disease onset ranging from 7 months to 10
years: onset under one year–five patients; onset 3–5 years (two patients); onset 8–10 years–
three patients. Only one participant used oxygen during the interview, while two participants
reported using oxygen during strenuous activities in daily life. All participants were Caucasian.
Eight participants attended the interview on their own (one of whom was interviewed at
home) and two attended with their spouses. In these latter interviews, the participant’s spouse
contributed to the discussion, simultaneously offering verification of the participant’s
responses, but also often encouraging further reflection or interpretation from the participant.
Inductive analysis of the patient interviews led to identification of seven second order
themes and eleven first order themes that are represented by two General Dimensions: Patient
experience with the condition and Patient-led recommendations for practice. An overview of
these themes and their hierarchical relationships with each other is shown in Fig 1.
General Dimension 1: Patients’ experiences of IPF
This General Dimension was underpinned by 4 second order themes (Social perception,
Depression, Accepting facts, and, Living with the condition) that mainly describe the psychoso-
cial impact of the disease on the patient, how it has affected his or her life, and the impact of
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IPF on the patient’s family members. These second order themes were derived from (and
reflect) both negative and positive responses from the participants, and were categorised col-
lectively as they relate to the same shared theme. The theme explanations below illustrate the
positive and negative responses provided by participants in relation to each theme.
Social perception. In this context, ‘social perception’ describes an individual’s experiences
of negotiating the social implications of IPF, including their feelings about how other people
perceive and treat them and how this impacts on their psychological well-being. Across all the
interviews, it was evident that participants and their close family members had little or no
knowledge of IPF before diagnosis, and most had not even heard the phrase IPF previously.
This lack of public awareness could be due to the limited availability of information about the
disease: “A lot of people don’t know what it is. They understand lung cancer but when it comes to
IPF they are like ‘what is that?’” (Patient J). This can lead to perceived prejudice: “When people
Fig 1. Key themes representing patients’ experiences of IPF and patient-led recommendations for practice.
https://doi.org/10.1371/journal.pone.0197660.g001
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see you coughing they say ‘take cough medicine, take this, take that’, they don’t understand it”
(Patient B) and “they would say, ‘why you are panting when you are doing nothing literally?’”
(Patient B). When patients face these kinds of responses on a daily basis they feel isolated and
somewhat stigmatised, which appeared to be contributing factors to the onset of depressive
symptoms in some patients.
Depression. Most of the patients interviewed displayed symptoms consistent with depres-
sion or low mood. This is likely attributable to the psychological trauma associated with their
disease, as noted by one participant who commented on what their diagnosis meant to them:
“Death. Certain, definite death.” (Patient H). Aside from feelings of depression a sense of vul-
nerability was also apparent among participants, adding to the feelings of depression, and this
appeared to stem from their lack of knowledge about the disease. The comments of two partic-
ipants illustrate this: “Lack of information always causes more worries” (Patient A) and “Well,
I’m in the dark about what you can do to help the condition” (Patient B). Inaccurate or misinter-
preted information about the nature and prognostic implications of IPF appears to be a com-
mon problem, as reflected in the perceptions: “If I was diagnosed with lung cancer it would have
knocked me over, but knowing I have a fighting chance as things are, it’s not bothering me”
(Patient E), and “I was pleased it wasn’t cancer” (Patient H).
The psychological trauma caused by the disease also appears to derive from altered percep-
tions of self: “I feel like a battery, your energy levels go down and you would have to stop” (Patient
J). When patients could not live up to their self-expectations and their previous self-percep-
tions of ability, they experienced feelings of self-pity that further fuelled their anxieties about
the debilitating nature of the disease. As one participant commented: “Sometimes I feel
ashamed about the things I can’t do” (Patient A). Another participant explained: “If I go out I
have to plan a route, that I know which is flat. So that I know, if I got to that point I can get back.
You have to think ‘if I can’t come back who am I gonna call to come pick me up?’. You know,
things like that. It really takes it out of you, it’s surprising to see how much it takes out of you.
After being there and doing something I feel like an old man of 90.” (Patient G, age 53). Further-
more, these IPF patients often experienced regret and frustration mainly due to the morbidity
of the disease and because they were being prevented from living their latter years as planned:
“I do get frustrated when it physically affects me, not being able to do things that I planned to do”
(Patient J) and “You plan to do all these things that you wanted to do all these years. But here we
are.” (Patient I).
Accepting facts. ‘Accepting facts’ refers to the stage at which all participants indicated
they had started to come to terms with the condition and attempted to move on with their
lives. As the quotes below illustrate, usually this began with accepting the fact that they have
the disease and it ended with the sense of achievement gained from being able to cope with
(and adapt to) living with the disease. When accepting the facts about, and the consequences
of, the disease, most participants were initially optimistic: “I was determined to live my life to
the fullest” (Patient A) and “I told myself ‘you have to try anything and everything’” (Patient C).
This positivity and optimism was enhanced further when individuals felt that their lives
mattered, thereby nurturing their sense of self-worth. This derived in part from knowing that
there are people and groups in society who care about them: “I’ve had a leaflet from the lung
association” (Patient B). Once these participants had achieved acceptance of the disease, they
were able to adapt to the disease accordingly: “I learnt a few things like when it comes to climb-
ing steps it’s easier to breathe in when you take off the step and breath out when you land on the
step” (Patient G) and “If I am going out I need to plan a route which I know is flat” (Patient G).
Following on from this acceptance and adjustment, some participants attempted to engage
in physical activities, the successful completion of which gave them a sense of achievement.
This was cause for renewed optimism, and an increased commitment to self-care as they
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looked to the future with hope: “It was keeping my lungs clear (now I have a lot of mucus and
phlegm) and it felt better. When I was done, you felt that you have achieved something” (Patient
F). Hearing participants’ experiences, it was evident that overcoming fear of the disease and
accepting the facts about it represented the initial stage of moving towards an elevated quality
of life; individuals had a sense of starting to live again, despite living with the condition, and of
achieving some normality to their day-to-day lives. Once they had successfully navigated
through this life experience, patients were often able to ‘move on’, overcoming the psychologi-
cal trauma caused by the diagnosis and associated morbidity of the disease.
Living with the condition. These themes describe how the disease affected the daily lives
of the participants and the adaptations they had made to cope with the condition on a daily
basis. Overwhelmingly, IPF had a huge impact on the participants’ lifestyles: “I used to play a
lot of golf, swimming, cricket, you name it. I’ve had no problem, but now I’m a television viewer”
(Patient B) and “I’ve sometimes found lifting whatever across the garden these days is difficult,
but before it was easy” (Patient E).
Most of the interviewees had to change their lifestyles completely following diagnosis,
adjusting to living with the condition through planning and prioritizing activities. They men-
tioned “finding the simplest way to do things” and “I try to keep everything in precise order, so things
at the same place all the time” (Patient A) and “It’s sort of reorganizing your life, try and do every-
thing in one place before you move to another” (Patient B). Such modifications helped significantly
in overcoming the obstacles they faced due to the debilitating nature of the disease. Participants’
comments showed that the disease also affected their family members: “Thenmy daughter read it
and she was badly distressed and she kept it from me. When it’s sitting there in front of you, you
think OMG [Oh My God]” Patient H) and “My son had a shock when he saw me with the oxygen”
(Patient F). Interestingly, the participants did not discuss coping strategies employed by their fam-
ily members but some did mention protective behaviour in both directions. Some participants
mentioned protecting their family members, and others noted that family members protected
them, from some of the stark realities of the disease: “My daughter knows, my husband knows. He
has been very protective in a loving way. My son, haven’t told him” (Patient H).
General Dimension 2: Patient-led recommendations for practice
The second general dimension was made by three second order themes (support, patient opin-
ions and, exercise programme) which mainly describes patients opinion and thoughts on how
to minimise the impact of IPF on daily life and the positives and negatives of support available
for IPF patients. As above the theme explanations illustrates both the positive and negative
responses given by the participants in relation to each theme.
Immediate responses to diagnosis. Receiving initial information about IPF at the point
of diagnosis was a traumatic experience for participants. Most had never heard of the condi-
tion previously and the information presented a stark and upsetting prognosis: “It came as a
little bit of a shock. It affected me” (Patient I) and “Very shocked. Really upset at the time. Coming
to terms with it slowly” (Patient H). Two participants commented about the way in which they
were told about the disease: “They gave me a booklet and I wish I didn’t read it” (Patient H) and
“To give it to someone as soon as they diagnosed it, I think it was not a good idea” (Patient G).
The initial shock and unexpected diagnosis of a disease about which they were unaware left
many patients looking for someone to blame, as they felt somehow victimised by their diagno-
sis. However, they were unable to attribute this blame to someone or something, which only
added to the immense frustration and psychological trauma caused by their diagnosis: “I feel
picked on, I feel I haven’t smoked for all these years, I don’t drink, I’m not overly fat, why is this
happening to me?” (Patient G).
Patients’ experiences of coping with Idiopathic Pulmonary Fibrosis (IPF)
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Each of the study participants had an individual perspective on how to cope with the disease
and suggestions on how to improve the care and support available for IPF patients. Over-
whelmingly, one of the key factors identified was the lack of available and appropriate informa-
tion on the disease. Both ignorance and ambiguity about the disease contributed to the trauma
that they were already experiencing with their diagnosis: “They say you are like this and that’s
how you are going to end up like. And you think, what’s going to happen in between?” (Patient
G). Participants offered a number of suggestions on how to address this, including involving
patients in developing materials for other sufferers and giving patients a role in educating
health professionals, to help them to understand the patient’s experience of diagnosis and the
disease trajectory. One participant suggested that “Initially I will direct them to our support
group. Then I would ask someone who had experience of the condition and the rehabilitation pro-
gram to talk about rehab [sic], who can pass on their true feelings—not a clinical thing, somebody
talking from the heart who had done it” (Patient D). Another commented “I think you need it in
age groups, which would help” (Patient G), and another felt that “You should find out all the
facts, face up to the facts, accept what is inevitable and live accordingly” (Patient A). They felt
that these strategies would help future IPF patients to appropriately fill the information gap
they had experienced when they were diagnosed with the disease.
Support. Participants’ comments indicated that support from others could be perceived
as either a positive or a negative influence. Most of the participants experienced positive sup-
port after their diagnosis with IPF, from either family or peers and not surprisingly this was
viewed as very important in helping them to accept the disease and to overcome the depression
they experienced: “They would do anything if I ask my family” (Patient A). The peer support
they experienced mainly came from the monthly support group that these participants
attended and, as was the case with family support, support from others with the disease was
perceived as vital in overcoming feelings of depression and adapting to living with the condi-
tion: “The positive is that I’ve met people similar, some of them are very nice’ (Patient A) and
“There was company, people with the same disease. I found I was looking forward to going. And I
thought it was doing me good” (Patient H). Others discussed the informal educational role this
peer support played: “We have a cup of tea, cake and we talk about how things are. They get peo-
ple from different ways of life to talk about the problem” (Patient F) and “Just having a chat
about families and how they are coping, you know that’s the biggest part of it. Getting together
and talking to people with the same problem’ (Patient F). Some found comfort in just seeing
other people who are in a worse condition than them: “. . .but it was nice to see there were people
worse than I was” (Patient G).
Although the support group was an incredibly powerful coping mechanism for the partici-
pants, its influence was not consistently positive: “I couldn’t help thinking that this is like Ship-
man’s waiting room

, waiting for each one to pop off you know. Because there is always news that
somebody is gone and that’s a person you know and I think, my name would be there one day
wouldn’t it?” (Patient A) [

Dr Harold Shipman was a notorious General Practitioner in the UK
who was convicted of murdering (via euthanasia) several of his elderly patients]. This patient also
discussed the impact of a shared common fate: “. . .down turn because you all know that you
are going sooner than you’d like to be”.
Family support was perceived in a similar vein: overall it was received positively but this
was not always the case. For example, a number of respondents discussed that family members
contributed to their lack of independence by making decisions about their lifestyles for them,
or by doing things for them that (with some effort) they were still able to do for themselves.
One participant commented “I got told off by my daughter for cutting the grass. But I got to do
it. I got to do it when I get the chance” (Patient F), whilst another noted “Eventually she is talking
about us moving downstairs and staying downstairs once it gets to a certain point—well I don’t
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want that. I’d rather take 10 minutes to go upstairs to go to bed than staying downstairs all the
time” (Patient G).
Exercise programmes. Study participants felt that physical exercise could benefit them
physically and could positively influence their mental well-being, helping them to deal with
their feelings of depression and to simply carry on with life. They discussed the benefits they
had experienced from exercise: “Mentally I feel good” (Patient D), “I find it useful for circulation
on the legs” (Patient I), “I’m sleeping better on the days I was doing it” (Patient G) and “I found
after exercising I slept better, woke up better and it improved my flexibility. Mentally you are feel-
ing better too and it helps” (Patient I). However, participants’ experiences of exercise did not
always remain positive over time owing to the high oxygen demand of exercise and the nega-
tive effects of this for some patients: “I found it a struggle” (Patient C) and “I found it was a
struggle, because I’m out of breath when I do it” (Patient D).
Patients’ comments indicated that they preferred group activities when it came to exercise
programmes, for example: “It was about meeting others too” (Patient C) and “You met people
and after that you got a cup of tea, sat down and had a chat. It was nice. But you won’t get that in
a gym” (Patient G) and “There was company, people with the same disease. I found I was looking
forward to going. And I thought it was doing me good” (Patient H).
Discussion
Idiopathic pulmonary fibrosis (IPF) is a life-limiting disease that has no curative options [1]
and this condition is little-recognised and poorly-understood by the general public. From a
patient’s perspective a diagnosis of IPF is therefore often completely unexpected and confus-
ing, provoking a range of psychological responses that cause much anxiety. A better apprecia-
tion of patients’ personal experiences of being diagnosed (and then coping) with IPF is critical
to changing the way we educate and support newly-diagnosed patients about their condition.
Our exploration of individual experiences of IPF offers insight into the psychosocial implica-
tions of IPF, its impacts on psychological and physical well-being, and the physical and psy-
chological coping strategies that patients adopt to cope with these. This has enabled us to
present here some patient-led recommendations for healthcare workers to support IPF
patients from the point of diagnosis and throughout the progression of their disease. We ana-
lysed our data inductively to allow themes to be generated from the data rather than using a
deductive theory-driven approach [12]–further discussion of this approach is provided in
S2 File.
Patients’ experiences of IPF
IPF and need-thwarting. Our participants told us that they had experienced insensitive
and unsympathetic comments regarding their condition and the struggles they faced each day,
leading them to feel less related to (and more isolated from) others in wider society (reduced
relatedness satisfaction). The majority of participants said that, because of this, they had lim-
ited their social interactions and confined themselves to a ‘safe space’ among family, close
friends and sometimes the weekly IPF support group. Russel et al. claimed that a poor under-
standing of IPF amongst the general public contributes to the emotional impact of IPF on
patients (depression, fear, frustration and isolation), causing them to withdraw from social
relationships [11]. This reduced social interaction results in an unfulfilled need for relatedness
(need-thwarting) in these individuals and negatively influences their overall well-being and
quality of life. Schoenheit et al. made similar observations, claiming that IPF patients express
difficulties in maintaining relationships owing to others’ lack of awareness and understanding
of the disease [8]. Sampson et al. observed that deterioration in health caused patients to
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restrict their activities (by confining them to indoors) rather than seeking assistance to maxi-
mise their functional activities (through socialising and conducting outdoor activities), thereby
increasing the risk of social isolation and leading to diminished possibilities [9]. Similarly Swi-
gris et al. reported that some patients avoided engaging with crowds of people simply because
of the fear of catching a respiratory disease that could lead to their demise [13]. Bonella et al.
suggested that awareness of IPF among the general public should be increased through cam-
paigns emphasising the chronic and debilitating nature of the disease [14]. Our participants’
responses were consistent with depressed mood, indicating that their sense of incompetence,
lack of autonomy and lack of intrinsic motivation were having a substantial negative impact
on their well-being.
Not surprisingly, given its physically-restrictive nature, IPF had a substantial impact on
patients’ satisfaction regarding the need to feel competent. This impact was especially apparent
in the execution of what were previously simple, taken-for-granted daily activities. The patients
we interviewed often experienced signs of breathlessness and fatigue during the simplest of
physical activities like walking or moving an object from one place to another. In addition,
most of our participants had previously been involved in sport or other recreational activities
such as walking prior to the onset of IPF, and no longer being able to participate in these activ-
ities further thwarted their need to feel competent. This need-thwarting leads to frustration
and was one of the most common observations we made during our interviews, along with a
sense of shame and self-pity that stemmed from the morbidity impact of IPF. Patients’ reduced
competence satisfaction was fuelled by the thwarting of their need for autonomy as most had
to seek help in carrying out the activities of daily living. Often family members stepped in to
help these patients even before their help was solicited; whilst participants appreciated their
help, family members were unknowingly undermining the individual’s sense of autonomy and
thus their competence satisfaction. Previous studies have similarly reported that patients’
inability to perform routine daily tasks negatively impacts on their emotional wellbeing [8,13].
Patients interviewed by Swigris et al. commented that the most detrimental aspect of this dis-
ease is the fact that they are less independent than previously, leading to a loss of privacy
because they needed help from others [13].
A lack of understanding about the disease compounds this situation. Patients are reluctant
to participate in physical activity because they are afraid of its possible impact on their condi-
tion, further reducing autonomy and competence-need satisfaction. Carers are often unsure
how to help patients and express concerns regarding the monitoring of breathing, coughing
and the use of oxygen [9]. Sampson et al. reported that patient-clinician consultations are
mostly disconnected from the demands of practical day-to-day life. Patients often feel that
they cannot interpret disease-focused assessments (like lung function tests) in relation to pre-
dicted future exercise capacity, causing them to simply avoid physical activity (presumably as a
conservative approach to avoiding exacerbation) [9]. Cicutto et al. [15] also found similar atti-
tudes to exercise in COPD patients, as did Fernandez et al. [16] in cancer patients, illustrating
that this is a common observation in the literature relating to many chronic diseases.
Coping mechanisms and re-establishing need-satisfaction. There was evidence that our
participants had also developed coping mechanisms that employed emotion-, problem-,
appraisal-, approach- or support-focused strategies that helped them restore need-satisfaction
after diagnosis. It was apparent that for many individuals the key to coping with IPF was an
acceptance of the reality of their condition, as this subsequently led to a sense of optimism.
During the early stages of diagnosis (following initial emotional upheaval) participants used
appraisal-focused coping strategies to purposely change their perspectives–this allowed them
to start thinking more positively and to gain some determination to live the remainder of life
to the fullest. One such example of this positive thinking and optimism was seen in a patient
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who had bought football tickets for the following season whilst knowing that his condition
meant he had a relatively low likelihood of living to watch the games. Others have also
observed that patients and family members try to maintain a normal life for as long as possible
by living in the moment, while acknowledging that this is difficult as the disease progresses
[10].
Participants used emotion-focused coping to overcome depression and to face the reality of
their condition, mainly through the opportunities for emotional expression that the IPF sup-
port group offered. As Folkman and Lazarus [17] suggested, emotion-focused coping was
employed alongside social support from others who shared their experience in the support
group. The simultaneous use of emotion-focused coping and social support was also evident
in the participants’ discussions of how family and friends had helped them to overcome the
initial trauma and fear of diagnosis. Importantly, their recognition of the support and care
from others helped to restore both lost self-worth and relatedness-satisfaction. The support
group also functioned to facilitate problem-focused coping as individuals could exchange
knowledge and experiences about the disease and provide tips on how to cope with the condi-
tion, which they would be unlikely to receive from a medical professional. There are however
some negative associations with support groups. For example, Lindell et al. observed that
health-related quality of life was diminished after patients had attended a six-week support
group (although other benefits were reported, including reduced feelings of isolation in
patients and reduced stress in their care partners)[7]. Sampson et al. suggested that seeing peo-
ple in support groups who are further ahead in terms of disease progression threatens the abil-
ity of some patients to cope with the condition [9].
Participants’ effective employment of support-, appraisal- and emotion-focused strategies
for coping with the wider psychological and personal implications of IPF meant that they were
then able to use problem-focused coping to deal with daily challenges. They did so by adapting
to their condition using small adjustments to the ways in which they conducted previously
taken-for-granted activities. Sampson et al. stated that patients use a day-by-day coping strat-
egy to adapt to their condition [9]. Swigris et al. observed that the majority of patients in their
study were forced to plan everything ahead, leading them to analyze every activity before start-
ing it [13]. Being able to accommodate the challenges IPF presents to once again conduct activ-
ities of daily living, such as going for a walk, provided a sense of achievement and led to a
regained sense of competence and enhanced well-being. Some of our patients found comfort
in a somewhat unorthodox manner by feeling good about themselves after seeing patients who
were in a much worse condition than themselves.
Patient-led recommendations for need-satisfaction
Information. Lack of information is one of the main issues that IPF patients face. This led
many participants to feel uncertain about what they could and could not do after diagnosis.
They felt uninformed and unable to make accurate judgements of their competence to carry
out physical activities, resulting in the adoption of a sedentary lifestyle. The information given
to these patients on IPF at the point of diagnosis was presented in an information booklet
including general information on the disease, which emphasised life expectancy and what the
patient could expect to happen towards the end of their life. However, it offered little informa-
tion on what patients might expect to experience in the shorter term or how they might best
cope with the condition. This often caused shock, anxiety and trauma, and subsequently led to
depression-like symptoms in these patients. It should be noted that our patient were perhaps
advantaged in receiving such information: patients have previously commented that they do
not receive sufficient information on the practical management of the disease (ranging from
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advice on oxygen therapy, nutrition, exercise, the management of cough, managing breathless-
ness and, most importantly, how to cope with the disease towards the end of life) [8,9,11,14].
Others have noted that learning about the fatality of the disease is overwhelming for patients,
and that they often find the amount of information they received overpowering; these patients
instead prefer to be given information about the disease gradually [10]. In fact Bonella et al.
[14] highlighted ‘improved information sources’ as one of the five unmet needs in IPF care
after consulting eleven European patient advocacy groups (an initiative that led to the develop-
ment of the European IPF Patients’ Charter). Based on our participants’ stories we recommend
that the information given by health professionals should focus on living with IPF, maintain-
ing quality of life through lifestyle changes (planning and prioritising) and encouraging
patients to remain as physically active as possible. This would help patients to maintain feelings
of competence and autonomy, and would encourage a proactive coping approach in patients
from the point of diagnosis.
Support for need satisfaction. Family support plays a key role in maintaining the well-
being of IPF patients, so it would be beneficial if immediate family members also received edu-
cation about IPF and its effects on the lives of both the patient and themselves. Russel et al
found that caregivers were inadequately prepared for the role of the caregiver owing to a lack
of information about the disease and the absence of psychological support, resulting in an
inability to relate to the patient [11]. Sampson et al. recommended that the role of the carer
should change from ‘passive observer’ to ‘active member’ throughout the patient’s healthcare
pathway, and that they should have access to better advice and support to fulfil their role in
managing the domestic environment for patients [9]. This is an important aspect of providing
appropriate social support for patients, especially in relation to being physically active. We sug-
gest that an emphasis should be placed on how not to support these patients; for example,
immediate intervention to help patients when performing physical activity or activities of daily
living could thwart autonomy and competence satisfaction and lead to feelings of shame and
subsequently depression. Instead, family members could be encouraged to help patients
employ problem-based coping strategies, making lifestyle changes to enable continuation of
activities that they performed prior to diagnosis. Furthermore, it is highly recommended that
patients join an IPF-specific support group if such a facility is available. This will help them ful-
fil their needs for relatedness, while allowing them to obtain valuable knowledge about their
condition from fellow patients who are experiencing different stages of the disease. Impor-
tantly, this will help increase patients’ awareness of what to expect in the future, and peer
advice will assist them in employing proactive-coping strategies, with a view to maintaining
competence and autonomy need satisfaction. Comments from participants in this study indi-
cate that in general patients would benefit from participation in physical activities, especially
in a group setting. Such benefits might include improvements in physical or psychological
well-being (perhaps helping to restore competence satisfaction or to reduce feelings of social
isolation), although further studies are needed to provide evidence of this.
Limitations
Of the 50 patients approached 40 did not respond and the nature of our recruitment process
meant that we had no follow-up information about the reasons for lack of replies. Although
our sample was therefore restricted to ten participants we believe that data saturation had been
reached at this level so we are confident that our results are robust. The demographic of the
participants was quite focused and this might bias our results to a degree: 1) Participants were
all resident in Swansea (South West Wales) or its immediate surrounding areas; 2) Participants
were recruited from a single IPF support group which was part of the palliative care pathway
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of the local health board. This type of support system might not be generally available across
other health boards in the UK or in other countries, so our findings (especially those relating
to opinions on the support group) will be biased to this demographic; 3) The stage of disease
progression and the time since diagnosis for our patients ranged from 1–10 years and,
although this range is wide, the relatively small number of participants means there was some
clustering into early/late stages of disease progression. Recently-diagnosed participants are
likely to have different opinions about the disease and its impact on their lives compared to
those who have been living with the disease for much longer. For each of these reasons we
must be guarded in our interpretation of the results and in any attempt to generalise the find-
ings to wider populations.
Conclusions
Our study evaluated the experiences of local patients with IPF regarding their condition. It
offers novel findings that will help to inform much-needed changes in the practice of supporting
IPF patients to cope with their diagnosis and disease progression. By interpreting these experi-
ences within the theoretical frameworks offered by self-determination theory and the transac-
tional model of stress and coping, we add insight into the mechanisms that underpin the impact
of IPF on psychological well-being. Furthermore, our recommendations are strengthened by
their grounding in both theory and practice, and by ensuring that we considered the varying
personal experiences that are characteristic of living with IPF. Based on our findings, future sup-
port for patients with IPF would benefit from a clear focus on providing effective and consider-
ate communication about the disease. In addition, patients and their families should be better
informed about the potential benefits of attending peer support groups, and about the types of
coping strategies employed by their peers to ‘live better’ with their condition.
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